Overview
Breast cancer is considered the most common type of malignancies, it is the most frequently diagnosed representing around 2.3 million cases. Where, their chemotherapy may cause fatigue affecting the overall quality of patient's life. Gait and balance are fundamental for activities of daily living and maintaining functional independence.
Description
Gait disturbance is one of the side effects that occur after chemotherapy due to various reasons resulting in lower values of quality of life. Chemotherapeutic agents can cause muscle wasting particularly in the lower extremities resulting in reduced strength and balance. Gait dysfunction, and falls may have particularly severe consequences in this population due to comorbidities increasing the risk of fall-related injury. Therefore, this study was designed to assess gait parameters in breast cancer patient receiving chemotherapy to assist in designing on optimal rehabilitation program based on objective data derived from our study for gait dysfunction in breast cancer patients receiving chemotherapy.
Eligibility
Inclusion Criteria:
- Age ranged from 40 to 50 years old.
- Female patients.
- Suffering from breast cancer, and receiving chemotherapy.
- Will be assessed before chemotherapy, 3 months and 6 months after chemotherapy.
- All enrolled patients will have signed their informed consent signed.
Exclusion Criteria:
- No history of prior chemotherapy.
- Current metastases.
- Orthopedic problems that affect balance and gait.
- Diabetic patients with neuritis.
- Peripheral neuropathy.
- Polyarthritis.
